Analyst firms · Jefferies · AMPH

Jefferies AMPH price target and rating history

Amphastar Pharmaceuticals Inc. (AMPH) · Health Care

Jefferies rates Amphastar Pharmaceuticals Inc. (AMPH) Hold with a $22 price target, as of its latest action on Apr 21, 2026. It has published 3 rating actions on AMPH since October 2022, including 0 upgrades and 1 downgrade. Across 4 firms with a AMPH price target in the last 12 months, the median target is $21. Jefferies's $22 is 5% above that.

Current rating

Hold

Price target

$22

Median target, all firms

$21

Actions on AMPH

3

Jefferies price target on AMPH

Every Jefferies rating on AMPH

• Apr 21, 2026
  DowngradeJefferies downgrades to Hold from Buy, price target $22
• Jul 25, 2023
  ResumeJefferies resumes coverage at Buy, price target $70
• Oct 21, 2022
  ResumeJefferies resumes coverage at Buy, price target $36

How other firms rate AMPH

Each firm's latest rating and stated target in the last 12 months.

Questions about Jefferies and AMPH

What is Jefferies's price target for AMPH?

Jefferies's latest stated price target for Amphastar Pharmaceuticals Inc. (AMPH) is $22, from its action on Apr 21, 2026.

What is Jefferies's rating on AMPH?

Jefferies rates AMPH Hold, a neutral rating, as of Apr 21, 2026.

When did Jefferies last change its view on AMPH?

On Apr 21, 2026, Jefferies downgrades to Hold from Buy, price target $22.

How does Jefferies's AMPH target compare with other analysts?

Across 4 firms with a AMPH price target in the last 12 months, the median target is $21. Jefferies's $22 is 5% above that.

More AMPH rating histories

• Piper Sandler3

All Jefferies ratingsAMPH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.